Completed PHASE4 INTERVENTIONAL 8-arm NCT01847872

IPV Clinical Trial - The Gambia (IPV)

A Phase 4, Randomized Trial to Assess the Safety and Immunogenicity of Inactivated Poliovirus Vaccine When Given Concomitantly With Measles and Rubella Combined Vaccine and Yellow Fever Vaccine at Nine Months and When Administered Via Different Vaccination Routes

Sponsor: London School of Hygiene and Tropical Medicine

Conditions Poliomyelitis

Interventions IPV ID Device IPV ID Needle IPV IM Device IPV IM Needle

Updated 7 times since 2017 Last updated: Mar 20, 2018 Started: Jul 31, 2013 Primary completion: Apr 30, 2015 Completion: Jul 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Poliomyelitis, this trial is completed. The trial is conducted by London School of Hygiene and Tropical Medicine and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Apr 2018 [monthly]

Completed PHASE4

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

London School of Hygiene and Tropical Medicine

Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fajara, The Gambia